Caroline Robert News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Reporting that the Islamic State who claimed responsibility for the killings has pledged a campaign of terror. Theresa may overhauling the Honours System also makes the papers front page. And finally, the mirror leads on the latest claims over George Michaels death. We will start with the ongoing hunt for the gunman who struck the Istanbul Nightclub last night. We we re Istanbul Nightclub last night. We were reporting it around this time, two oclock in the morning local time, last night. Smiling killer, it says. Shot victims one by one as they partied with friends. Hundreds and hundreds of peo...

Hello, again. Im martha raddatz. Great to have you with us. If second terms are about building a legacy this was an incredibly tough week for president obama, who this morning is still facing withering attacks on his signature legislative achievement health care reform. And more troubling for the white house, democrats are joining in. We have full coverage of the president s very rough week, lets begin at the white house where Jonathan Karl has the very latest. Good morning, jon. Reporter president obama has staked his legacy on the Affordable Care act, but now the flawed rollout threatens to ...

Department veterans, the most significant revelation in the post report is this. The special counsel told trumps lawyers that he is preparing a report about the president s actions while in office and potential obstruction of justice. According to two people with knowledge of the conversations. A former federal prosecutor told me muellers report doesnt preclude mueller from indicting literally everybody else, but trump will be dealt with just like ken starr dealt with president clinton. The report puts the impeachment process in motion. Joining us to discuss his remarkable reporting, one of th...

CHICAGO — Sequencing encorafenib plus binimetinib with nivolumab and ipilimumab did not delay disease progression in adults with advanced BRAF-mutated melanoma, results from a randomized phase 2 trial showed. However, findings presented at ASCO Annual Meeting suggest that individuals with elevated lactate dehydrogenase or liver metastases may benefit from the treatment regimen.

Follow-up results from phase II study show 12-month EFS rate of 89% in stage II-IV disease